Found 57 ne-neurology trials
A listing of ne-neurology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
This is a Phase 3 study, which means that BIIB093 (study drug) has already been investigated in previous clinical research studies with a small number of people with large hemispheric infarction (LHI). These studies suggested that the study drug was safe, did not cause serious side effects or discomfort, and …
The research is being conducted to study the relationship between blood pressure and blood flow in your brain. By making these measurements before and after implantation of your left ventricular assist device (LVAD), this study will help understand how the LVAD affects blood flow to your brain.
The research study is being conducted in order to determine whether Transcranial Direct Current Stimulation (tDCS) paired with cognitive training can improve thinking abilities in persons with stroke. There will be a total of five stimulation sessions. During the tDCS stimulation, you will be asked to participate in cognitive training.
TEGSEDI (also known as inotersen) is a medicine that has been approved in the United States, Europe and Canada to treat polyneuropathy (nerve damage) caused by hereditary transthyretin amyloidosis (hATTR-PN) in adults. hATTR-PN is a rare genetic disease that worsens over time if left untreated. This research study will examine …
The purpose of this study is to validate a video-administered cognitive assessment for use by the Alzheimer's Disease Research Centers and other research programs whose activities have been interrupted by the COVID19 pandemic, as well as for use in future initiatives when remote testing will enhance achievement of scientific goals. …
The overall study objectives include evaluating the long-term safety and tolerability of Staccato alprazolam in patients with stereotypical prolonged epilepsy. The study will evaluate the probability of success of repeated treatment with Staccato alprazolam and of repeated treatment with Staccato alprazolam with no recurrence of seizure(s) up to 2 hours …
Primary Objective: To determine changes in neurodegeneration over the first year of treatment with anti-amyloid monoclonal antibodies Secondary Objectives: To identify measures that detect and monitor neuroinflammation during anti-amyloid treatment. To explore the interaction between neuroinflammation and neurodegeneration Primary Endpoint: Neuroimaging and blood-based measures of neurodegeneration, cognitive performance Secondary Endpoints: …
Open label extension of RISE, a study of BHV7000 in patients 18+ with focal epilepsy.
Create a foundational resource for conducting and sharing ATN imaging and blood biomarker results in the context of the large clinically heterogenous brain-donor-enrolled multi-ADRC cohort. These imaging-plasma sets will be intrinsically linked to cognitive and neurobehavioral data collection, genetics and eventually neuropathology.
Please choose between Voice or SMS based delivery of verification code
or